Pharmacy-Direct EC Access Insurance Cost Savings Estimated In AJPH Study
This article was originally published in The Tan Sheet
Executive Summary
Non-prescription access to emergency contraceptives could reduce the medical costs of unplanned pregnancies by over $30 for public insurers and up to $180 for private payers per woman, depending on the type of therapy used, according to a study published in the September issue of the American Journal of Public Health.
You may also be interested in...
OTC Emergency Contraceptive Application Nearing FDA Panel Review
Women's Capital Corporation's application to switch its Plan B emergency contraceptive from Rx to OTC status is expected to be considered by an FDA advisory panel in mid December
OTC Emergency Contraceptive Application Nearing FDA Panel Review
Women's Capital Corporation's application to switch its Plan B emergency contraceptive from Rx to OTC status is expected to be considered by an FDA advisory panel in mid December
OTC Emergency Contraceptive Application Nearing FDA Panel Review
Women's Capital Corporation's application to switch its Plan B emergency contraceptive from Rx to OTC status is expected to be considered by an FDA advisory panel in mid December